Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Accumulated Expenses (2020 - 2021)

Stemtech (STEK) has disclosed Accumulated Expenses for 2 consecutive years, with $23000.0 as the latest value for Q4 2021.

  • Quarterly Accumulated Expenses rose 9.52% to $23000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $23000.0 through Dec 2021, up 9.52% year-over-year, with the annual reading at $23000.0 for FY2021, 9.52% up from the prior year.
  • Accumulated Expenses hit $23000.0 in Q4 2021 for Stemtech, down from $402137.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $402137.0 in Q3 2021 to a low of $21000.0 in Q4 2020.